69 reports

  • NETHERLANDS HEALTHCARE PROVIDERS SECTOR DISTRIBUTION: % SHARE, BY VALUE, 2019
  • DRIVERS OF SUPPLIER POWER IN THE HEALTHCARE PROVIDERS SECTOR IN THE NETHERLANDS, 2019

TABLE ##: NETHERLANDS HEALTHCARE PROVIDERS SECTOR VALUE: $ BILLION, 2015-## FIGURE ##: NETHERLANDS HEALTHCARE PROVIDERS SECTOR VALUE: $ BILLION, 2015-## ##.

  • Healthcare
  • Netherlands
  • Market Size
  • Fresenius Group
  • ORPEA group
  • Factors influencing the likelihood of new entrants in the pet healthcare market in the Netherlands, 2017
  • Netherlands pet healthcare market value: $ million, 2013-17

MARKET DATA MARKET VALUE Table ##: Netherlands pet healthcare market value: $ million, 2013-## Figure ##: Netherlands pet healthcare market value: $ million, 2013-## The Dutch pet healthcare market grew by ##. ##% in 2017 to reach a volume of ##. ## million unit

  • Healthcare
  • Netherlands
  • Bayer AG
  • Nutreco N.V.
  • Rolf C Hagen Inc

It additionally explores the level and growth of expenditure on healthcare, new drugs and ongoing research studies.

  • Healthcare
  • Pharmaceutical
  • Netherlands
  • Demand
  • Market Size

The Future of Netherlands Healthcare Products and Services Markets to 2025 ## Table of Contents ##. ## List of Tables ##. ## List of Figures ## Netherlands Healthcare Products and Services Market Overview, 2018 ##. ## Introduction to Netherlands Healthcare Products and Servi

  • Healthcare
  • Netherlands
  • Trade
  • ICT MARKET OPPORTUNITY IN THE HEALTH CARE SECTOR BY SEGMENT: STORAGE INFRASTRUCTURE, USD
  • ICT MARKET OPPORTUNITY IN THE HEALTH CARE SECTOR BY SEGMENT: NETWORK INFRASTRUCTURE, USD

Within the body of this report Kable present the market size and forecast spending trends for the sector which covers: TABLE ##: CATEGORY DEFINITIONS Domain Category Definition cards are now almost always built into PCs as a standard.

  • Healthcare
  • ICT
  • Netherlands
  • Market Segment
  • Market Size

However, even without the drop in drug prices, the Dutch healthcare system was one of the most efficient in Europe.

  • Healthcare
  • Netherlands
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Novartis AG
  • Netherlands: Self-Monitoring of Blood Glucose (SMBG) Market (Million US$), 2010 - 2017
  • 9.3 Blood Glucose Devices (SMBG) Market (2010 - 2024)

Figure ##-##: Worldwide: Healthcare Spending on Diabetes (Billion US$), 2010 & 2030 Most countries aspire to deliver effective, safe, and affordable healthcare to their citizens.

  • Diabetes
  • Healthcare
  • Netherlands
  • Scandinavia
  • Forecast
  • CAGR (2018-2023): 3.8%
  • Further reading

SUMMARY TREND AND KPIS ##.

  • Healthcare
  • Netherlands
  • Achmea Schadeverzekeringen N.V.
  • ASR Schadeverzekering N.V.
  • Menzis Zorgverzekeraar N.V.
  • PARTNERSHIPS

The company' s deal volume decreased from six pharmaceuticals & healthcare deals in 2016 to one pharmaceuticals & healthcare deal in 2017.

  • Healthcare
  • Pharmaceutical
  • Therapy
  • Netherlands
  • Merus Labs International Inc.

The company' s deal volume increased from one pharmaceuticals & healthcare deal in 2016 to six pharmaceuticals & healthcare deals in 2017.

  • Healthcare
  • Netherlands
  • Demand
  • M&A
  • Royal DSM N.V.

Netherlands Telemedicine Market Forecast to 2022 - by Services and Technology, By Clinical Applications (Tele Psychiatry, Tele Dermatology, Tele Assistance, Tele Consultation and Others) ##.

  • E-Healthcare
  • Healthcare
  • Telemedicine
  • Netherlands
  • Market Size

Europe is one of the best regions in world, where healthcare provider is well aligned and diabetes institutional network are properly scattered to capture the whole demography.

  • Healthcare
  • Netherlands
  • United Kingdom
  • Forecast
  • Market Size

GlobalData Impatients NV' s, deal volume decreased from two pharmaceuticals & healthcare deals in 2016 to one pharmaceuticals & healthcare deal in 2017.

  • Healthcare
  • Pharmaceutical
  • Netherlands
  • Supply
  • Impatients, N.V.

The company' s deal volume increased from zero pharmaceuticals & healthcare deals in 2016 to one pharmaceuticals & healthcare deal in 2017.

  • Biotechnology
  • Healthcare
  • Therapy
  • Netherlands
  • Hookipa Biotech AG

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expen

  • Healthcare
  • Infectious Disease
  • Pathology
  • Netherlands

GlobalData Syncom BV' s, deal volume increased from one pharmaceuticals & healthcare deal in 2016 to two pharmaceuticals & healthcare deals in 2017.

  • Healthcare
  • Pharmaceutical
  • Netherlands
  • Deals & Alliance
  • Erasmus MC, Pharmaceuticals & Healthcare, Deal Details
  • GILDE HEALTHCARE ACQUIRES MAJORITY STAKE IN VIROCLINICS BIOSCIENCES FROM ERASMUS MC

GlobalData Erasmus MC' s, deal volume decreased from one pharmaceuticals & healthcare deal in 2016 to zero pharmaceuticals & healthcare deals in 2017.

  • Health Services
  • Healthcare
  • Pharmaceutical
  • Netherlands
  • Deals & Alliance

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expen

  • Healthcare
  • Infectious Disease
  • Pathology
  • Netherlands
  • Maastricht University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • MAASTRICHT UNIVERSITY, PHARMACEUTICALS & HEALTHCARE, DEALS BY THERAPY AREA, 2012 TO YTD 2018

GlobalData Maastricht University' s, deal volume decreased from one pharmaceuticals & healthcare deal in 2016 to zero pharmaceuticals & healthcare deals in 2017.

  • Education And Training
  • Healthcare
  • Pharmaceutical
  • Netherlands
  • Deals & Alliance
  • Xenikos BV, Pharmaceuticals & Healthcare, Deal Details
  • Xenikos BV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018

The company' s deal volume decreased from one pharmaceuticals & healthcare deal in 2016 to zero pharmaceuticals & healthcare deals in 2017.

  • Healthcare
  • Pharmaceutical
  • Therapy
  • Netherlands
  • Supply
  • Treeway BV, Pharmaceuticals & Healthcare, Deal Details
  • Treeway BV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018

GlobalData Treeway BV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 Deal Type Partnerships Licensing Agreement No. of Deals ## ## Deal Value (US$ million) NA NA Treeway BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 Treeway BV, Ph

  • Dementia
  • Healthcare
  • Netherlands
  • Company
  • Deals & Alliance
  • AGILEBIOTICS BV, PHARMACEUTICALS & HEALTHCARE, DEALS SUMMARY, 2012 TO YTD 2018

GlobalData Deal Type Equity Offerings Partnerships Venture Financing No. of Deals ## ## ## Deal Value (US$ million) NA NA NA AGILEBIOTICS BV, PHARMACEUTICALS & HEALTHCARE, DEALS BY REGION, 2012 TO YTD 2018 AGILEBIOTICS BV, PHARMACEUTICALS &

  • Healthcare
  • Pharmaceutical
  • Netherlands
  • Deals & Alliance
  • Gadeta BV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018
  • Gadeta BV, Deals By Therapy Area, 2012 to YTD 2018

GlobalData Gadeta BV, reported one pharmaceuticals & healthcare deal in YTD 2018.

  • Healthcare
  • Medical Biotechnology
  • Pharmaceutical
  • Netherlands
  • Company
  • CIMAAS BV, PHARMACEUTICALS & HEALTHCARE, DEALS SUMMARY, 2012 TO YTD 2018

GlobalData CiMaas BV, reported one pharmaceuticals & healthcare deal each in 2016 and 2017.

  • Healthcare
  • Medical Biotechnology
  • Netherlands
  • Company
  • Deals & Alliance

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expen

  • Healthcare
  • Infectious Disease
  • Pathology
  • Netherlands

The company' s deal volume increased from zero pharmaceuticals & healthcare deals in 2016 to one pharmaceuticals & healthcare deal in 2017.

  • Healthcare
  • Therapy
  • Netherlands
  • Company
  • ISA Pharmaceuticals B.V.

GlobalData Synthon Holdings BV, reported one pharmaceuticals & healthcare deal each in 2016 and 2017.

  • Healthcare
  • Netherlands
  • Company
  • Deals & Alliance
  • Supply
  • LICENSING AGREEMENTS

GlobalData Lava Therapeutics BV, reported one pharmaceuticals & healthcare deal worth $##. ## million in YTD 2018.

  • Healthcare
  • Pharmaceutical
  • Therapy
  • Netherlands
  • Deals & Alliance
  • Okklo Life Sciences BV, Pharmaceuticals & Healthcare, Deal Details

GlobalData Okklo Life Sciences BV' s, deal volume increased from zero pharmaceuticals & healthcare deals in 2016 to one pharmaceuticals & healthcare deal in 2017.

  • Healthcare
  • Pharmaceutical
  • Netherlands
  • Deals & Alliance
  • Supply

GlobalData Crossbeta Biosciences BV' s, deal volume decreased from two pharmaceuticals & healthcare deals in 2016 to one pharmaceuticals & healthcare deal in 2017.

  • Healthcare
  • Pharmaceutical
  • Netherlands
  • Deals & Alliance